The compounders and the telehealth companiesthe targets, so to speakare in talks right now with private-equity groups and with VC firms. To prepare for the FDA decision, Noorian says that Empower has been prepping for months, including doing R&D to ensure that its formulations are stable and that it can offer peptides as injections, pills and nasal sprays to meet expected demand
The discussion of GHK-Cu oral vs injectable for these goals is settled
That near-parity underpins the prevailing model of this copper peptide as a physiological copper shuttle rather than an inert chelator, and a ternary GHK-Cu-albumin complex has since been characterised directly
"Expression of glycosaminoglycans and small proteoglycans in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu(2+)"
NNMT (nicotinamide N-methyltransferase) is the enzyme 5-Amino-1MQ inhibits, and tissue expression varies significantly across organs: adipose tissue shows 812 higher NNMT activity than skeletal muscle, which is why subcutaneous injection near adipose depots produces localised effects rodent models couldn't predict
LPS within research limits